Naučne publikacije akademskog osoblja
Datum kreiranja: 23.01.2014.

Ivana Damnjanović

Dodatne informacije

  • Lični podaci

  • Datum rođenja: 03.07.1983. godine
  • Mesto rođenja: Leskovac
  • Obrazovanje

  • Fakultet: Medicinski fakultet
  • Odsek / Grupa / Smer: Farmacija
  • Godina diplomiranja: 2007.
  • Spisak publikacija

  • Knjige i udžbenici:

    1. Radmila Veličković-Radovanović, Aleksandra Catić-Đorđević, Ivana Damnjanović, Nikola Stefanović. Priručnik iz farmakokinetike. Urednik: Radmila Veličković-Radovanović, Medicinski fakultet Niš, Niš, 2015.


    1. Radmila Veličković-Radovanović, Aleksandra Catić-Đorđević, Ivana Damnjanović (saradnik), Nikola Stefanović (saradnik). Farmakoepidemiologija. Urednik: Radmila Veličković-Radovanović, Medicinski fakultet Niš, Niš, 2014.

  • Radovi u časopisima sa IMPACT faktorom:

    1. Damnjanovic I, Kocic G, Najman S, Stojanovic S,Tomovic K, Ilic B ,Veljkovic A, Pesic S, Smelcerovic A. Possible molecular mechanisms and pathways involved in BH3 mimetic activity of alpha-lipoic acid on human colon cancer cell line. Farmacia 2019;  67( 2): 226-234. M23 (IF: 1,507).


    1. Damnjanovic I, Kitic D, Stefanovic N, Velickovic-Radovanovic R. Reply to Letter to the Editor: Herbal self-medication use in Type 2 diabetes mellitus. Turk J Med Sci 2016; 46: 1275-1276. (Научна критика и полемика M26, IF:0.325, 5-IF:0.372 )

    2. Velickovic-Radovanovic R, Stefanovic N, Damnjanovic I, Kocic B, Antic S, Dinic M, Petrovic J, Mitic R,  Catic-Djordjevic A. Monitoring of antibiotic consumption and development of resistance by enterobacteria in a tertiary care hospital. J Clin Pharm Ther 2015; 40 (4): 426-430. (M23, IF:1.833, 5-IF:1.804)

    3. Damnjanovic I, Kitic D, Stefanovic N, Zlatkovic - Guberinic S, Catic - Djordjevic A, Velickovic - Radovanovic R. Herbal self - medication use in patients with diabetes mellitus type 2. Turk J Med Sci 2015; 45: 964-971. (M23, IF: 0.841, 5-IF:0.633)

    4. Damnjanovic I, Najman S, Stojanovic S, Stojanovic D, Veljkovic A, Kocic H, Langerholc T, Damnjanovic Z, Pesic S. Crosstalk between possible cytostatic and antiinflammatory potential of ketoprofen in the treatment of culture of colon and cervix cancer cell lines. Bratisl Lek Listy. Bratisl Lek Listy 2015; 116(4): 227-232. (M23, IF: 0.439, 5-IF:0.406)

    5. Damnjanovic I,  Kocic G, Najman S, Stojanovic S, Stojanovic D, Veljkovic A, Conic I, Langerholc T, Pesic S. Chemopreventive potential of alpha lipoic acid in the treatment of culture of colon and cervix cancer cell lines. Bratisl Lek Listy 2014; 115 (10): 610-616. (M23, IF: 0.446, 5-IF:0.463)

    6. Damnjanovic Z, Jovanovic M, Nagorni A, Radojkovic M, Sokolovic D, Damnjanovic G, Djindjic B, Smiljkovic I, Kamenov A, Damnjanovic I.  Povezanost inflamatornih parametara i biohemijskih markera holestaze sa intenzitetom lipidne peroksidacij kod bolesnika sa holedoholitijazom.Vojnosanit  Pregl 2013; 70(2): 170-176. (M23, IF: 0.210.)

    7. Conic I, Miljkovic S, Tošic-Golubovic S, Stanojevic Z, Milenkovic D, Djordevic B, Damnjanovic I, Visnjic M, Antic S, Stefanovic V. Anxiety levels related to type of terapy for cervical cancer. Central European Journal of  Medicine 2012; 7(4): 490-496. (M23, IF: 0.262, 5-IF:0.265)

    8. Damnjanovic Z, Jovanovic M, Bogdanovic D, Smiljkovic I, Ilic N, Damnjanovic I. Relationship between the incidence of idiopathic lower extremity deep vein thrombosis and the location of the thrombus with changesof atmospheric pressure. Chirurgia (Bucur) 2012; 107(4): 483-487.  (M23, IF: 0.777)

    9. Kocic G, Pavlovic V, Saranac Lj, Kocic R, Zivic S, Sokolovic D, Jevtovic T, Nikolic G, Stojanovic S, Damnjanovic I. Circulating nucleic acids in type 1 diabetes may modulate the thymocyte turnover rate. Cell immunol 2010; 266(1): 76-82. (M23, IF: 2.575, 5-IF:2.333)

  • Radovi u ostalim časopisima:

    1. Stefanović N, Veličković-Radovanović R, Catić-Djordjević A, Damnjanović I, Dinić K, Mitić B, Jevtović-Stoimenov T, Bašić J, Despotović M, Cvetković T. Interindividual and intraindividual pharmacokinetic variability of tacrolimus within the first year after renal transplantation: effect of CYP3A5 gene polymorphism. Acta Medica Medianae 2019; 58(1): 93-101.

    2. Stefanović N, Cvetković T, Dinić K, Mitić B, Paunović G, Damnjanović I, Catić-Đorđević A, Veličković-Radovanović R. Influence of Different Formulations of  Tacrolimus on Dosage Regimen and Drug Exposure Within the First Year After Kidney Transplantation. Hospital Pharmacology 2019; 6(2): 774-784.

    3. Damnjanović I, Kocić G, Najman S, Stojanović S, Tomović K, Ilić B, Veljković A, Šmelcerović A. Molecular mechanisms of potential synergistic effect of  ketoprofen and meloxicam with conventional cytostatics in human cervix cancer cell line. Acta Medica Medianae 2018; 57(4): 52-59.

    4. Damnjanović I, Kitić D, Stefanović N, Zlatković–Guberinić S, Catić–Đorđević A, Veličković–Radovanović R. The use of herbal dietary supplements in diabetic patients: role of healthcare professionals. Acta Medica Medianae. Doi broj: 10.5633/amm.2017.0404. In press

    5. Veličković-Radovanović R, Stefanović N, Damnjanović I, Petrović J, Mitić R, Kocić B, Antić S, Dinić M,  Catić-Đorđević A.  The Analysis of Antibiotic Consumption and Bacterial Resistance in Tertiary Healthcare Centre Niš. Hospital Pharmacology 2016; 3(1):341-347. 

    6. Veličković-Radovanović R, Stefanović N, Damnjanović I, Petrović J, Mitić R, Lilić R, Kocić B, Antić S, Dinić M, Catić-Đorđević A. Monitoring of the cephalosporins consumption in the tertiary care hospital. Acta Medica Medianae 2015; 54(2): 31-36. 

    7. Damnjanović I, Velickovic - Radovanovic R, Kocic R, Zlatkovic-Guberinic, Sokolovic D, Djindjic, N, Conic I. Uticaj beta blokatora na insulinsku rezistenciju kod pacijenata sa dijabetes melitusom tip 2. Acta Medica Medianae 2011;50(4):23-28.

    8. Damnjanovic I, Kitic D, Zlatkovic-Guberinic S, Milosavljevic J, Conic I. Savremeni aspekti upotrebe Valerianae officinalis. Acta Medica Medianae 2010;49(3):65-70.

    9. Damnjanovic I,Velickovic - Radovanovic R, Catic - Djordjevic A, Kocic R, Ciric V, Conic I, Bjelakovic LJ. Farmakokineticko i farmakodinamicko modeliranje bazalnih insulin i analoga. Acta Medica Medianae 2009;48(1):15-19.

    10. Damnjanovic Z, Nagorni A, Kocic G, Blagojevic Z, Mančić Dj, Damnjanovic I. Praćenje biohemijskih parametara holestaze I intenziteta oksidativnog stresa kod bolesnika sa holedoholitijazom. Acta Medica Medianae 2008; 47(3): 21-27.

    11. Conic I, Stanojevic Z, Dedović I, Lilic G. Anksioznost i depresivnost kod bolesnica sa karcinomom grlića materice pre operativnog lečenja. Acta Medica Medianae 2008;47(2): 49 -53. 

  • Radovi na naučnim skupovima međunarodnog značaja:

    1. Damnjanovic I, Kocic G, Najman S, Stojanovic S, Veljkovic A, Pešic S. NF-kB as potential chemopreventive target of meloxicam in the treatment of colon cancer cells in vitro. VI Serbian congress of pharmacy, October 15th-19th, 2014, Belgrade, Serbia, Abstract book: 256-257.

    2. Catić-Đorđević A, Stefanović N, Dimitrijević M, Damnjanović I, Ninčić J, Veličković-Radovanović R. The role of clinical pharmacist in community pharmacy. VI Serbian congress of pharmacy, October 15th-19th, 2014, Belgrade, Serbia,Abstract book: 231-232.

    3. Catic-Djordjevic A , Stefanovic N, Dimitrijevic M, Damnjanovic I, Pavlovic S, Velickovic-Radovanovic R. Safety and potential risk of self-medication in Nis region. 48. Days of preventive medicine, September  23th-26th, 2014, Niš, Serbia, Abstract book:255.

    4. Damnjanović I, Kitic D, Stefanovic N, Zlatkovic-Guberinić, Catic-Djordjevic A, Velicković-Radovanović R. Use  of  herbal  dietary  supplements  in  patients  with diabetes  mellitus type 2. 49. Days of preventive medicine, September  22th-25th, 2015, Niš, Serbia,Abstract book: 54.

    5. Damnjanović I, Catić Đorđević A, Stefanović N, Zlatković Guberinić S, Milošević D, Veličković Radovanović R. Influence of health care professionals in preventing medication errors. 50. Days of preventive medicine, September  22th-25th, Niš 2016, Abstract book:234.

Poslednji put izmenjeno petak, 13 decembar 2019 11:58